Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-04-16 @ 12:56 PM
Study NCT ID:
NCT03391934
Status:
RECRUITING
Last Update Posted:
2023-04-05
First Post:
2017-12-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer
Sponsor:
Cinnagen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CET.CIN.HR.96 (III)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None